# Xtandi

NDC: 0469-0125
Generic name: enzalutamide
Labeler / Manufacturer: Astellas Pharma US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20120831

FDA application: NDA203415

## Active ingredients

- ENZALUTAMIDE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0469-0125"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0469-0125
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf